Adjuvant Lung Cancer Enrichment Mark Identification and Sequencing Trial (ALCHEMIST) (Alliance A151216)
This phase III ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Contact
Clinical Trials Office at [email protected] or (203) 358-8879.
Principal Investigator(s)
Salvatore Del Prete, MD
Sponsor(s)
Alliance for Clinical Trials in Oncology
Location
Bennett Cancer Center
One Hospital Plaza
Stamford, CT 06902
Main: 203-358-8879
Stamford, CT 06902
Main: 203-358-8879